Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Sulfonamide antimicrobials such as sulfamethoxazole (SMX) have been associated with drug hypersensitivity reactions, particularly in patients with AIDS. A reactive oxidative metabolite, sulfamethoxazole-nitroso (SMX-NO), forms drug-tissue adducts that elicit a T-cell response. Antioxidants such as ascorbic acid (AA) and glutathione (GSH) reduce SMX-NO to the less reactive hydroxylamine metabolite (SMX-HA), which is further reduced to the non-immunogenic parent compound by cytochrome b (5) (b5) and its reductase (b5R). We hypothesized that deficiencies in AA and GSH would enhance drug-tissue adduct formation and immunogenicity toward SMX-NO and that these antioxidant deficiencies might also impair the activity of the b5/b5R pathway. We tested these hypotheses in guinea pigs fed either a normal or AA-restricted diet, followed by buthionine sulfoximine treatment (250 mg/kg SC daily, or vehicle); and SMX-NO (1 mg/kg IP 4 days per week, or vehicle), for 2 weeks. Guinea pigs did not show any biochemical or histopathologic evidence of SMX-NO-related toxicity. Combined AA and GSH deficiency in this model did not significantly increase tissue-drug adduct formation, or splenocyte proliferation in response to SMX-NO. However, combined antioxidant deficiency was associated with decreased mRNA and protein expression of cytochrome b (5), as well as significant decreases in SMX-HA reduction in SMX-NO-treated pigs. These results suggest that SMX-HA detoxification may be down-regulated in combined AA and GSH deficiency. This mechanism could contribute to the higher risk of SMX hypersensitivity in patients with AIDS with antioxidant depletion.
Bhusari
Sachin
S
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706-1102, USA.
Abouraya
Mahmoud
M
Padilla
Marcia L
ML
Pinkerton
Marie E
ME
Drescher
Nicholas J
NJ
Sacco
James C
JC
Trepanier
Lauren A
LA
D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D000975:Antioxidants / Q000378:metabolism; D001205:Ascorbic Acid / Q000378:metabolism*; D001206:Ascorbic Acid Deficiency / Q000378:metabolism*; D049109:Cell Proliferation / Q000187:drug effects; D042966:Cytochrome-B(5) Reductase / Q000235:genetics / Q000378:metabolism; D015786:Cytochromes b5 / Q000235:genetics / Q000378:metabolism*; D004342:Drug Hypersensitivity / Q000378:metabolism; D005978:Glutathione / Q000172:deficiency* / Q000378:metabolism; D006168:Guinea Pigs; D008658:Inactivation, Metabolic; D008099:Liver / Q000378:metabolism; D008297:Male; D013420:Sulfamethoxazole / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity; D013601:T-Lymphocytes / Q000187:drug effects
D000890:Anti-Infective Agents; D000975:Antioxidants; C059873:sulfamethoxazole hydroxylamine; D015786:Cytochromes b5; D042966:Cytochrome-B(5) Reductase; D005978:Glutathione; D013420:Sulfamethoxazole; D001205:Ascorbic Acid